|
2024
|
Invention
|
Methods of treating cancer using anti-cd22 antibody oligonucleotide conjugates. The present discl... |
|
|
Invention
|
Use of immunomodulating targeted polynucleotide conjugates for use with immune honing agent. e.g.... |
|
|
Invention
|
Sirp-alpha antibodies and conjugates.
The present disclosure provides anti-SIRP-α polypeptide an... |
|
|
Invention
|
Nectin-4 antibodies and conjugates.
The present disclosure provides nectin-4 antibodies and olig... |
|
2023
|
Invention
|
Transglutaminase-mediated conjugation.
The present disclosure provides for antibody-oligonucleot... |
|
|
G/S
|
clinical research in the field of pharmaceuticals, biotechnology, and biopharmaceuticals; providi... |
|
2022
|
Invention
|
Sirp-alpha antibodies and conjugates. The present disclosure provides anti-SIRP-α polypeptide ant... |
|
|
Invention
|
Sirp-alpha antibodies and conjugates. The present disclosure provides anti-SIRP-? polypeptide ant... |
|
|
Invention
|
Nectin-4 antibodies and conjugates. The present disclosure provides nectin-4 antibodies and oligo... |
|
|
Invention
|
Transglutaminase-mediated conjugation. The present disclosure provides for antibody-oligonucleoti... |
|
2021
|
Invention
|
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use.
Immunom... |
|
|
Invention
|
Transglutaminase-mediated conjugation.
The present disclosure provides methods for conjugating a... |
|
|
Invention
|
Transglutaminase-mediated conjugation. The present disclosure provides methods for conjugating an... |
|
2020
|
G/S
|
Pharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-c... |
|
2019
|
Invention
|
Immunomodulating polynucleotide conjugates and methods of use.
Provided herein is a conjugate fo... |
|
|
Invention
|
Immunomodulating polynucleotide conjugates and methods of use. Provided herein is a conjugate for... |
|
2018
|
Invention
|
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use. Immunomo... |
